Designer Benzodiazepines, Screen With Confirmation, Urine Clinical
Use
Detect use of designer benzodiazepine drugs
Special Instructions
Sample collection involves using a plastic urine container without preservatives. The specimen should be frozen to ensure stability and avoid degradation of the compounds being tested. This test requires no special patient preparation aside from standard urine collection procedures.
Limitations
The test is designed to detect a specific panel of designer benzodiazepines. Negative results do not preclude the presence of other substances not included in the test panel. Additionally, the stability of the urine specimen is dependent on proper freezing, as samples that remain at room temperature or are refrigerated may become unstable and unsuitable for accurate analysis. Results should be interpreted in the context of clinical findings and other supporting laboratory data.
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 14316-4
- 14316-4
- 3390-2
Result Turnaround Time
7-10 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
10 mL
Minimum Volume
1 mL
Container
Plastic urine container without preservative
Collection Instructions
Collect urine in a plastic urine container without preservative.
Storage Instructions
Freeze.
Causes for Rejection
Urine in preservative container
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Not Stable |
| Refrigerated | Not Stable |
| Frozen | 21 days |